Page last updated: 2024-11-01

nomifensine and Behavior Disorders

nomifensine has been researched along with Behavior Disorders in 2 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vallvé Leal, C1
Harvey, NS1

Reviews

1 review available for nomifensine and Behavior Disorders

ArticleYear
Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality.
    Psychosomatics, 1986, Volume: 27, Issue:2

    Topics: Antidepressive Agents; Clozapine; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Female;

1986

Other Studies

1 other study available for nomifensine and Behavior Disorders

ArticleYear
[Scientific validity of phase IV clinical trials].
    Archivos de farmacologia y toxicologia, 1979, Volume: 5, Issue:3

    Topics: Adult; Clinical Trials as Topic; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Fema

1979